ANKRD40

Model summary

A human nucleocytoplasmic scaffold that uses ankyrin repeats and a C‑terminal ubiquitin‑like module to assemble transcriptional regulatory complexes. By organizing partner proteins without intrinsic catalytic activity, it modulates RNA polymerase II–dependent gene expression in both directions—stabilizing repressors to dampen transcription and engaging co‑activators to enhance it. The soluble architecture supports cytosolic preassembly and nucleoplasmic action, where it fine‑tunes promoter‑proximal complexes that determine transcriptional output.

Predicted Gene Ontology terms

1. 01

   I begin with the domain architecture.

   The N-terminus (residues 1–110) is covered by IPR036770, an ankyrin repeat-containing domain superfamily, and within this region sits a canonical ankyrin repeat array annotated as IPR002110 (Ankyrin repeat, residues 9–75). Ankyrin repeats form elongated solenoid scaffolds that create versatile protein–protein interaction surfaces; this architecture causes broad, multivalent binding capacity rather than enzymatic catalysis. The entire polypeptide is classified as IPR039195 (Ankyrin repeat domain-containing protein 40 family, residues 1–368), indicating a conserved scaffold specialized for regulatory assemblies. At the C-terminus, IPR060551 (ANKRD40-like, ubiquitin-like domain, residues 265–338) adds a compact ubiquitin-like fold that typically mediates regulated docking to ubiquitin/ubiquitin-like pathways and transcriptional complexes. The ordered layout—N-terminal ankyrin-repeat scaffold followed by a C-terminal ubiquitin-like docking module—predicts a modular adaptor that assembles and tunes macromolecular regulatory complexes.

2. 02

   From this architecture, the primary molecular function resolves to protein binding (GO:0005515).

   Ankyrin repeats supply the avid, modular binding platform, while the ubiquitin-like domain refines partner selection and timing. The absence of catalytic motifs and the presence of interaction-centric folds reinforce a role as a non-enzymatic regulator.

3. 03

   This binding-centric design naturally supports transcriptional control.

   The ankyrin scaffold can recruit transcription factors and chromatin regulators, while the ubiquitin-like domain enables dynamic association with co-regulatory machinery. Such assemblies can either repress or potentiate transcription depending on the partners engaged. This dual regulatory logic explains participation in both negative regulation of transcription by RNA polymerase II (GO:0000122) and positive regulation of transcription by RNA polymerase II (GO:0045944). Mechanistically, the ankyrin array can stabilize repressor complexes at specific promoters, whereas the ubiquitin-like module can switch to co-activator contexts, for example by engaging mediator or chromatin-opening factors.

4. 04

   Cellular localization follows from function and architecture.

   Transcriptional regulation requires nucleoplasmic residency, and the soluble, non-membranous fold composition supports a nucleoplasmic pool (GO:0005654 nucleoplasm). Many transcriptional regulators shuttle and assemble in the cytosol before nuclear entry; the soluble scaffold and ubiquitin-like docking therefore also support a cytosolic population (GO:0005829 cytosol). This nucleocytoplasmic distribution aligns with a model where assembly and post-translational routing occur in the cytosol, followed by nuclear engagement of target genes.

5. 05

   Integrating these lines, I hypothesize that the protein operates as a nucleocytoplasmic ankyrin-repeat scaffold that tunes RNA polymerase II transcription.

   In the cytosol, it likely preassembles with chaperones and ubiquitin-pathway adaptors via its ubiquitin-like domain. It then accumulates in the nucleoplasm where it binds transcription factors and chromatin-modifying complexes to modulate promoter output bidirectionally. Likely partners include transcriptional repressors and activators, mediator subunits, and chromatin remodelers; together they determine whether the assembled complex enhances or dampens transcriptional initiation and elongation.